<DOC>
	<DOCNO>NCT00346840</DOCNO>
	<brief_summary>The primary objective study assessment efficacy four dose reservoir ( 25 mcg , 50 mcg , 100 mcg , 200 mcg ) intravaginal control release misoprostol administer 24 hour . Efficacy measure term time insert placement vaginal delivery .</brief_summary>
	<brief_title>Safety Efficacy Study Misoprostol Vaginal Insert Induction Labour</brief_title>
	<detailed_description>Approximately 20 % pregnant woman require medical intervention induce labour reason include post-date pregnancy , pre-eclampsia , maternal diabetes , premature rupture membrane intra-uterine fetal growth retardation . There two fundamental change characterise pre-labour preparation delivery : sensitisation myometrium produce contraction , ripen ( soften dilation ) cervix . Prostaglandins ( PG ) fundamental change , several form use successfully induce labour . Dinoprostone ( PGE2 ) example cervical ripening agent available gel tablet form proven record successful cervical ripen population . Dinoprostone also available controlled release vaginal delivery system , manufacture Controlled Therapeutics ( Scotland ) subsidiary Cytokine PharmaSciences , Inc. , King Prussia , PA , USA . Another synthetic prostaglandin show effective cervical ripener labour inducer misoprostol . Oral tablet broken fragment use intravaginally ripen cervix induce labour Due disadvantage exist cervical ripeners ( delivery bolus dos , freezer refrigerate storage , lack efficacy labour induction ) , due safety concern off-label use oral misoprostol tablet fragment , Controlled Therapeutics develop controlled release vaginal delivery system similar market dinoprostone product contain misoprostol . This study examine four dose strength misoprostol vaginal insert woman need labour induce .</detailed_description>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>At term ( 37 42 week inclusive gestation ) . Aged 18 year old . One previous full term delivery ( least 37 week gestation ) . Singleton pregnancy . Cephalic presentation ( normal lie ) . Bishop score 6 determine MBS criterion . Uncomplicated pregnancy judge physician . Written informed consent . four previous full term delivery . Previous uterine surgery , include Csection surgery cervix uterus ( cone biopsy cervix permit ) . In spontaneous labour . Administration oxytocin tocolytic drug cervical ripen labour inducing agent prior enrolment ( within seven day enrolment ) . Suspected cephalopelvic disproportion . Evidence suggestion fetal distress . Subject receive NSAID ( include aspirin ) within four hour study treatment ( topical permit ) . Pyrexia ( oral aural temperature &gt; 37.5C ) . Unexplained genital bleeding pregnancy 24 week . Current pelvic inflammatory disease , unless adequate prior treatment institute . Placenta praevia . Known suspected allergy misoprostol prostaglandin . Prior serious adverse event relate prostaglandin administer route indication . Subject unable comply requirement protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Labor induction</keyword>
	<keyword>cervical ripening</keyword>
	<keyword>misoprostol</keyword>
	<keyword>vaginal insert</keyword>
</DOC>